2012
DOI: 10.1016/j.trsl.2011.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Altered angiogenic balance in keloids: a key to therapeutic intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
46
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(50 citation statements)
references
References 29 publications
3
46
0
1
Order By: Relevance
“…Less scar formation in fetal skin and oral mucosa might be related to an inferior inflammatory response and a much faster maturation of newly formed capillary networks [57]. New therapies for hypertrophic scars or even keloids have therefore been suggested using anti-angiogenic treatments, although the distinct underlying mechanism is still unclear [57,60,61]. DiPietro [57] concluded in her review article that at first, it might seem odd to diminish angiogenesis during skin wound repair.…”
Section: Angiogenesis In Skin Wound Healingmentioning
confidence: 99%
“…Less scar formation in fetal skin and oral mucosa might be related to an inferior inflammatory response and a much faster maturation of newly formed capillary networks [57]. New therapies for hypertrophic scars or even keloids have therefore been suggested using anti-angiogenic treatments, although the distinct underlying mechanism is still unclear [57,60,61]. DiPietro [57] concluded in her review article that at first, it might seem odd to diminish angiogenesis during skin wound repair.…”
Section: Angiogenesis In Skin Wound Healingmentioning
confidence: 99%
“…A prenatal or oral injury leads to a less pronounced inflammatory reaction as well as angiogenesis and is accompanied by (almost) scar-free wound healing (Table 1) [47,48]. Further studies have also shown that increased VEGF levels and increased vascularity could be observed in patients with hypertrophic or keloid scars (Table 1) [49,50]. The blockade of VEGF or an anti-angiogenic therapy, e.g., using bevacizumab, showed significantly reduced formation of intra-abdominal adhesions and hypertrophic scars [51,52].…”
Section: Phase 2: Anti-angiogenic Phase or Regressionmentioning
confidence: 99%
“…3 VEGF was not only highly expressed in local keloid tissues, but also elevated in serum in patients with keloids scars compared with normal population. 31 June 2017…”
Section: Vascular Endothelial Growth Factor (Vegf)mentioning
confidence: 99%